Latest News

Thursday, March 26, 2015 | Medical Studies

Findings of Study on Photoscreening Presented at AAPOS Revealing the Clinical Efficacy and Efficiency of Mobile Smartphone Vision Screening for Preschoolers

On Saturday, March 28, a new study will be presented at AAPOS entitled: "Efficacy of a Mobile SmartPhone Vision-Screening Device with Automated Image-Processing Analysis in the Evaluation of Ambl…

Read the full story

Thursday, March 26, 2015 | Earnings & Financials, Hoya Surgical Optics

Hoya Group Invests in SalutarisMD Wet AMD Therapy Technology

Hoya Group announced that it has closed financing in Salutaris Medical Devices (SalutarisMD), according to a company news release. SalutarisMD will use the funding to further its growth strategy in de…

Read the full story

Thursday, March 26, 2015 | Miscellaneous

Google Granted Patent for Smart Contact Lens

Google has been granted a patent for a contact lens with an embedded chip. The patent, which was discovered by WebProNews, features a sensor in the lens. Google has previously said that it is partneri…

Read the full story

Thursday, March 26, 2015 | Product Releases, Bausch+Lomb

Bausch + Lomb Announces Availability of Enhanced BLIS Reusable Injector System for enVista IOLs

Bausch + Lomb announced the availability of an enhanced BLIS Injector System, which is designed exclusively for use with the enVista hydrophobic acrylic IOL, according to a company news release. …

Read the full story

Thursday, March 26, 2015 | Miscellaneous

From Snitch Pill to Xbox Sensors, Novartis Goes Digital

A decade ago, Joe Jimenez was peddling ketchup and baked beans. Now he’s using Microsoft Corp.’s gaming technology and embedding Google Inc. sensors in contact lenses to reinvent the world…

Read the full story

Thursday, March 26, 2015 | Clinical Trials, Psivida

pSivida Corp. Completes Targeted Enrollment of Phase 3 Trial of Medidur for Posterior Uveitis

pSivida Corp. announced the completion of the originally targeted enrollment of 120 patients in its pivotal phase 3 clinical trial of Medidur for the treatment of posterior uveitis, according to a com…

Read the full story

Wednesday, March 25, 2015 | FDA Approval/Clearance, Regeneron Pharmaceuticals

Eylea Receives FDA Approval for the Treatment of Diabetic Retinopathy in Patients with DME

Regeneron Pharmaceuticals announced that the FDA has approved Eylea (aflibercept) injection for the treatment of diabetic retinopathy in patients with diabetic macular edema (DME), according to a comp…

Read the full story

Wednesday, March 25, 2015 | Santen

Santen Announces Approval of Ikervis for EU Marketing Authorization

Santen Pharmaceutical Co. announced it received approval of the Marketing Authorization Application (MAA) for Ikervis from the European Commission. Ikervis is approved for treatment of severe keratiti…

Read the full story

Wednesday, March 25, 2015 | Health Care

Lawmakers Propose Allowing Pharma Companies to Share Some Off-Label Information

A proposal under discussion in Congress would allow pharmaceutical companies to legally share what is considered off-label product information for FDA-approved drugs. The plan would essentially permit…

Read the full story

Wednesday, March 25, 2015 | Management/Leadership, Shire

Shire's Ophthalmics Business Unit Appoints Two New Members to Senior Leadership Team

Shire announced that it continues to advance its Ophthalmics Business Unit with the appointment of two new members to the senior leadership team -- Chris Pearson as head of oOphthalmics Business Uni…

Read the full story

Wednesday, March 25, 2015 | Partnerships

Ocata Therapeutics Licenses Induced Pluripotent Stem Cell Technology from Allele Biotechnology and Extends Leadership Position in Cell Therapy Capabilities

Ocata Therapeutics announced that it has entered into a definitive agreement with Allele Biotechnology & Pharmaceuticals, of San Diego, to access Allele’s propr…

Read the full story

Wednesday, March 25, 2015 | Medical Studies

A Pinch of Baking Soda for Better Vision?

Bicarbonate (baking soda) makes sparkling water sparkle, causes bread to rise, absorbs odors and can be used for cleaning all sorts of stuff, including your teeth. In the body, it plays essential role…

Read the full story

Tuesday, March 24, 2015 | Medical Studies

Study: Women at Higher Risk than Men for Most Eye Diseases, Yet One in Four Has Not Had an Eye Exam in Last 2 Years

According to the recent Prevent Blindness study, "The Future of Vision: Forecasting the Prevalence and Costs of Vision Problems," women make up the majority of the 4.4 million Americans age …

Read the full story

Tuesday, March 24, 2015 | Partnerships

Trefoil Therapeutics Development Program with Florida State University to Focus on the Treatment of Corneal Dystrophies

Trefoil Therapeutics announced the signing of a license and research agreement with Florida State University for the development of engineered FGF-1 derivatives (eFGF-1s), according to a company news …

Read the full story

Tuesday, March 24, 2015 | Clinical Trials, Aerie Pharmaceuticals

Aerie Completes Enrollment in Second Phase 3 Registration Trial (Rocket 2) of Rhopressa to Lower IOP in Patients with Glaucoma

Aerie Pharmaceuticals announced the completion of enrollment in the company’s second phase 3 registration trial (Rocket 2) of Rhopressa, a novel once-daily, triple-action eye drop being tested f…

Read the full story
Load More
 Stock Price  Change 
 Aerie Pharmaceuticals, Inc. $30.47  1.80% 
 Akorn, Inc. $46.27  1.34% 
 Alimera Sciences, Inc. $4.38  -5.60% 
 Allergan, Inc. $240.22  0.00% 
 Avalanche $38.40  -6.43% 
 Bayer $151.38  -1.32% 
 Can-Fite Biopharma $5.40  5.47% 
 Carl Zeiss Meditec $24.00  -0.21% 
 Cooper Companies, Inc. $185.09  0.37% 
 Escalon Medical Corp. $1.38  -2.13% 
 Essilor International $116.90  0.00% 
 Imprimis Pharmaceuticals, Inc. $7.98  -1.82% 
 InSite Vision, Inc. $0.19  -1.05% 
 IRIDEX Corporation $10.36  0.88% 
 Johnson & Johnson $100.14  -0.20% 
 LCA-Vision Inc. $5.37  0.00% 
 Luxottica Group, S.p.A. $62.56  -0.76% 
 Merck & Company, Inc. $57.60  -1.13% 
 NicOx $1.94  -0.56% 
 NovaBay Pharmaceuticals, Inc. $0.71  0.00% 
 Novartis AG Common Stock $99.56  -0.80% 
 Ocular Therapeutix $41.25  -0.34% 
 Ophthotech Corporation $47.03  -0.25% 
 Quantel $3.03  -0.33% 
 Regeneron $448.38  -1.24% 
 Roche $34.33  -1.61% 
 STAAR Surgical Company $7.25  -0.14% 
 TearLab Corporation $2.39  -5.16% 
 Thrombogenics $5.95  0.00% 
 Topcon Corporation $24.71  0.00% 
 Valeant Pharmaceuticals $198.46  0.74% 
 Xoma $3.59  -2.97%